台耳醫誌

雜誌專區 -第56卷第4期

病例報告 
Epithelial-Myoepithelial Carcinoma of the Salivary Glands-Report of Two Cases  僅供有效會員 登入會員查看全文
268~272 
英文 
epithelial-myoepithelial carcinoma、hard palate、salivary gland、上皮肌上皮細胞癌、硬顎、唾液腺 
Rui-Bin Yu1,2 、Chun-Hsiang Chang1-3 、Yi-Jia Chen1 、Hui-Jung Yu3,4 、Jeng-Wen Chen1-3  
Department of Otolaryngology–Head and Neck Surgery, Catholic Cardinal Tien Hospital1 、Department of Otolaryngology–Head and Neck Surgery, National Taiwan University Hospital2 、School of Medicine, Fu-Jen Catholic University3 、Department of Pathology, Catholic Cardinal Tien Hospital4  
Epithelial-myoepithelial carcinoma (EMC) is an uncommon, low-grade salivary gland neoplasm. It accounts for approximately 1% of all salivary gland tumors. The mean age of patients at diagnosis is 60 years, and 60% of patients with EMC are female. The most common sites are the parotid gland, submandibular gland, and minor salivary gland. We report 2 cases of salivary gland EMC. The first case is of a 59-year-old woman who presented with a left parotid mass. Computed tomography of the neck showed a lobulated heterogeneous enhanced mass in the superficial lobe. The Patient received surgical resection and postoperative radiotherapy. The second case is of a 66-year-old man who was diagnosed as having right hard palate EMC. The patient received operation only; he has been undergoing follow-up at an outpatient clinic, and no recurrence has yet been reported. This article reminds us that salivary gland EMC is an uncommon disorder, presented with a painless mass in salivary gland location. Surgery is the first-line treatment. Radiotherapy can be considered in the positive or close margin, tumor spillage, perineural invasion, or patients who are not surgical candidates. Prognosis is good, with a 10-year disease-specific survival rate exceeding 90%.(J Taiwan Otolaryngol Head Neck Surg 2021; 56:268-272)